Literature review never ends.
Science publishes 5M articles a year. Teams process less than 0.1% of the relevant information. Days of reading and still no clarity on which route is viable for your case.
A hybrid architecture that no single paper proposes: perovskite as photocatalytic pretreatmentP012 followed by immobilized laccase as enzymatic polishingP037.
Mass balance closes at >97% with OPEX comparable to a conventional MBR. Regulatory risk: the perovskite contains cobaltP089 — evaluate nickel-zinc as an alternative.
Science publishes 5M articles a year. Teams process less than 0.1% of the relevant information. Days of reading and still no clarity on which route is viable for your case.
In R&D the pattern repeats: the evidence exists in another industry, in another discipline. Arandi finds it and connects it back to your problem.
In the Fuzzy Front End, early decisions lock in up to 70–80% of a product’s cost. Getting it wrong can mean losses of hundreds of thousands or millions and months on dead-end routes — which is why validating before investing is critical.
Arandi is not a search engine and not a chatbot. It is an intelligence platform that decomposes your technical problem to first principles, searches verified scientific literature, extracts mechanisms document by document, and stays available to query at any time. Every claim traceable to its original source.
A guided conversation takes your stated problem to its first-principles formulation. The system does not advance until the problem is correctly scoped and you approve it.
The system proposes which lines to explore. You approve, modify or remove before a single analysis resource is spent.
Search across verified literature, mechanism-by-mechanism extraction, classification by role: direct evidence, cross-domain transfer, or context. Between 12 and 25 minutes.
You converse with your corpus. Every answer cites real papers with traceable badges. When you close, you generate a 2–3 page executive memo ready for the committee.
* Patent coverage on the 2026 roadmap.
The system stops twice and waits for your approval before spending resources analyzing the wrong question.
Every claim points to a verifiable source. If the source does not exist or cannot be validated, the system does not cite it.
Arandi detects when a solution comes from another field. The difference between finding more of the same and discovering a productive analogy.
If part of the analysis fails, the output says so up front. No documents that look complete when they aren’t.
Needs to remove veterinary drugs and residual hormones from industrial effluents. Hard constraints: room temperature, no pH pretreatment, limited OPEX. Three weeks reading papers without convergence.
Arandi reframed the problem as selective oxidative degradation of polar organic molecules in an aqueous matrix with calcium and lactose interference. It proposed three lines: advanced photocatalysis, immobilized enzymes, regenerable adsorbent materials. Carolina approved all three at Decision Gate 2.
A 3-page executive memo with recommendation, 5 key pieces of evidence, risks, declared gaps and traceable links back to Knowledge Chat.
Remove residual hormones and antibiotics from dairy effluents at room temperature, with no pH pretreatment, on a limited OPEX.
Reformulation: selective oxidative degradation of polar molecules in a matrix with Ca²⁺ and lactose. Three routes: photocatalysis · immobilized enzymes · regenerable adsorbents.
Hybrid architecture: photocatalytic perovskite + immobilized laccase as polishing. Cobalt regulatory risk documented.
A full Deep Dive on your real problem. No demos, no calls, no mandatory onboarding.
Everything in Free, plus team capacity, unlimited conversation and shared memory across projects.
No card · account in 90 seconds
If you don’t find your question, write to us — we respond fast and in technical language.
Private, isolated workspace with Row-Level Security. We do not train models on your content. Your workspace data never mixes with another organization’s.
It’s the threshold where the marginal cost of analysis is justified by the value of the additional document. More papers does not mean more insight — it means more noise without curation.
Every source goes through DOI verification. If we cannot confirm that the paper exists and that the claim is in the original text, the system does not cite it. No exceptions.
If it’s covered by OpenAlex — engineering, materials, chemistry, biotech, energy, agro, pharma — yes. If not, we tell you before charging you.
On the 2026 roadmap. Closed pilots get priority access when it enters beta.